Mitsuru Momose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mitsuru Momose has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Chisato Kondo
Tokyo Woman’s Medical University
13 shared publicationsNobuhisa Hagiwara
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan
9 shared publications- Kenji Fukushima
Department of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, Japan
8 shared publications Kiyoko Kusakabe
Tokyo Women’s Medical University
7 shared publicationsShuji Sakai
Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Japan
7 shared publicationsAtsushi Suzuki
Department of Cardiology, Tokyo Women's Medical University, Japan
5 shared publications
Latest Publications
- 11 April 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 432, 133273
Long term prognosis in cardiac sarcoidosis under FDG-PET guided immunosuppressive therapy
- 11 April 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 432, 133273
Long term prognosis in cardiac sarcoidosis under FDG-PET guided immunosuppressive therapy
- 1 June 2024
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 6 (3) , e230298
Risk Stratification Using Right Ventricular Longitudinal Strain Ratio Derived from 13N-Ammonia PET in Patients with Ischemic Heart Disease
Purpose To investigate whether right ventricular (RV) myocardial strain ratio (RVMSR) assessed using nitrogen 13 ammonia (13N-NH3) PET can predict cardiovascular events in patients with ischemic heart disease (IHD). Materials and Methods This retrospective study included 480 consecutive patients (mean age, 66 years ± 12 [SD]; 334 males and 146 females) with IHD who underwent 13N-NH3 PET. RVMSR was defined as the ratio of RV strain during stress to that at rest. The primary end point was major adverse cardiac events (MACEs), defined as cardiac death or heart failure hospitalization. The ability of RVMSR to predict MACE was assessed using receiver operating characteristic (ROC) curve and Kaplan-Meier analyses. Cox proportional hazards regression analysis was used to calculate hazard ratios (HRs) with 95% CIs. Results ROC curve analysis identified a sensitivity and specificity of 84% and 82%, respectively, for predicting MACE from RVMSR. Patients with reduced RVMSR (P < .001). Cox proportional hazards regression analysis of imaging parameters, including myocardial flow reserve, indicated that RVMSR was an independent predictor of MACE (HR, 0.94 [95% CI: 0.92, 0.97]; P < .001). Conclusion RVMSR was an independent predictor of MACE and has potential to aid in the risk stratification of patients with IHD. Keywords: Right Ventricular Myocardial Strain Ratio, Myocardial Flow Reserve, Ischemic Heart Disease, 13N-Ammonia Positron Emission Tomography Supplemental material is available for this article. © RSNA, 2024.
- 1 June 2024
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 6 (3) , e230298
Risk Stratification Using Right Ventricular Longitudinal Strain Ratio Derived from 13N-Ammonia PET in Patients with Ischemic Heart Disease
Purpose To investigate whether right ventricular (RV) myocardial strain ratio (RVMSR) assessed using nitrogen 13 ammonia (13N-NH3) PET can predict cardiovascular events in patients with ischemic heart disease (IHD). Materials and Methods This retrospective study included 480 consecutive patients (mean age, 66 years ± 12 [SD]; 334 males and 146 females) with IHD who underwent 13N-NH3 PET. RVMSR was defined as the ratio of RV strain during stress to that at rest. The primary end point was major adverse cardiac events (MACEs), defined as cardiac death or heart failure hospitalization. The ability of RVMSR to predict MACE was assessed using receiver operating characteristic (ROC) curve and Kaplan-Meier analyses. Cox proportional hazards regression analysis was used to calculate hazard ratios (HRs) with 95% CIs. Results ROC curve analysis identified a sensitivity and specificity of 84% and 82%, respectively, for predicting MACE from RVMSR. Patients with reduced RVMSR (P < .001). Cox proportional hazards regression analysis of imaging parameters, including myocardial flow reserve, indicated that RVMSR was an independent predictor of MACE (HR, 0.94 [95% CI: 0.92, 0.97]; P < .001). Conclusion RVMSR was an independent predictor of MACE and has potential to aid in the risk stratification of patients with IHD. Keywords: Right Ventricular Myocardial Strain Ratio, Myocardial Flow Reserve, Ischemic Heart Disease, 13N-Ammonia Positron Emission Tomography Supplemental material is available for this article. © RSNA, 2024.
- Open Access
- 1 November 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1127)
Coronary flow quantification estimated by dynamic 320-detector CT angiography: validation by 13N ammonia PET myocardial flow reserve
Objectives: Resting coronary flow index (rCFI) estimated by 320-detector low-dose dynamic coronary CT angiography (CCTA) is a direct flow quantification using intracoronary attenuation. We propose modified-rCFI from new protocol combining dynamic scan and standard CCTA using dose-modulation, and validate its consistency with quantitative values and ischemia depicted by 13N-ammonia PET (NH3-PET). Methods: 46 patients who underwent dynamic CCTA and NH3-PET for coronary artery disease were evaluated using original rCFI in 21 patients and modified-rCFI in 25 patients. Two types of rCFI were calculated for three major coronary arteries. Myocardial blood flow (MBF) at rest and stress, myocardial flow reserve (MFR), and the presence or absence of ischemia for three major territories were depicted by NH3-PET. Coronary territories were categorized as territories with MFR 3-PET, and were consistent with a high specificity in detecting functional ischemia. Advances in knowledge: rCFI can contribute as additional functional test over standard CCTA in clinical work-up.
- 1 November 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1127)
Open AccessCoronary flow quantification estimated by dynamic 320-detector CT angiography: validation by 13N ammonia PET myocardial flow reserve
Objectives: Resting coronary flow index (rCFI) estimated by 320-detector low-dose dynamic coronary CT angiography (CCTA) is a direct flow quantification using intracoronary attenuation. We propose modified-rCFI from new protocol combining dynamic scan and standard CCTA using dose-modulation, and validate its consistency with quantitative values and ischemia depicted by 13N-ammonia PET (NH3-PET). Methods: 46 patients who underwent dynamic CCTA and NH3-PET for coronary artery disease were evaluated using original rCFI in 21 patients and modified-rCFI in 25 patients. Two types of rCFI were calculated for three major coronary arteries. Myocardial blood flow (MBF) at rest and stress, myocardial flow reserve (MFR), and the presence or absence of ischemia for three major territories were depicted by NH3-PET. Coronary territories were categorized as territories with MFR 3-PET, and were consistent with a high specificity in detecting functional ischemia. Advances in knowledge: rCFI can contribute as additional functional test over standard CCTA in clinical work-up.
- Open Access
- 14 June 2019
- Published by Springer Nature in European Journal of Hybrid Imaging
- Vol. 3 (1) , 1-13
Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and 18F fluorodeoxyglucose positron emission tomography
Diagnosis and evaluation of cardiac sarcoidosis (CS) are mainly based on the combined use of cardiac magnetic resonance imaging (CMR) and 18F fludeoxyglucose positron emission tomography (FDG). Though these modalities can detect the pathological feature of the disease, combined assessment has not been fully examined. Multimodality image fusion is known to be useful for further comprehension, while most image interpretation is performed with a side by side comparison in clinical routine. We investigated the similarity and discrepancy of active inflammation, regional fibrosis, and wall function by image fusion of CMR and FDG. Patients with CS who underwent both CMR and FDG were retrospectively enrolled. The extent of myocardial late gadolinium enhancement (LGE) in left ventricle (LGE volume), cardiac function, and volume (left ventricular ejection fraction, LVEF; end-diastolic volume, EDV) was measured from CMR. The FDG uptake in whole myocardium (whole SUVmax), cardiac metabolic volume (CMV), and cardiac metabolic activity (CMA) was calculated from FDG. CMR and FDG were fused and divided into AHA 17 model for segmental analysis. Wall motion, the magnitude of LGE in myocardial wall (LGE%wall), and corresponding FDG uptake (segmental SUVmax) were analyzed. Forty-one patients were retrospectively enrolled. In patients with FDG uptake, LVEF inversely correlated to LGE volume and positively correlated to SUVmax (r = − 0.56, p < 0.0001, and r = 0.08, p = 0.048, respectively). Discrepancy between LGE volume and CMV showed a significant positive correlation to whole SUVmax and CMA (r = 0.49, p < 0.0001, and r = 0.96, p < 0.0001, respectively). In image fusion analysis, segmental SUVmax showed a significant inverse correlation to LGE%wall (Spearman’s rank correlation coefficient; r = − 0.15, p = 0.008). LGE%wall also showed significant inverse correlation to wall motion (r = − 0.13, p = 0.0011). Combined and fusion analysis with CMR and FDG demonstrated the discrepancy of myocardial inflammation and extensive fibrosis. Active inflammation was present in the earlier stage of myocardial fibrosis and was found to be less in the wall with advanced fibrosis and remodeling. Combined analysis of CMR and FDG can incrementally reclassify the pathological stage of CS.
- 14 June 2019
- Published by Springer Nature in European Journal of Hybrid Imaging
- Vol. 3 (1) , 1-13
Open AccessDiscrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and 18F fluorodeoxyglucose positron emission tomography
Diagnosis and evaluation of cardiac sarcoidosis (CS) are mainly based on the combined use of cardiac magnetic resonance imaging (CMR) and 18F fludeoxyglucose positron emission tomography (FDG). Though these modalities can detect the pathological feature of the disease, combined assessment has not been fully examined. Multimodality image fusion is known to be useful for further comprehension, while most image interpretation is performed with a side by side comparison in clinical routine. We investigated the similarity and discrepancy of active inflammation, regional fibrosis, and wall function by image fusion of CMR and FDG. Patients with CS who underwent both CMR and FDG were retrospectively enrolled. The extent of myocardial late gadolinium enhancement (LGE) in left ventricle (LGE volume), cardiac function, and volume (left ventricular ejection fraction, LVEF; end-diastolic volume, EDV) was measured from CMR. The FDG uptake in whole myocardium (whole SUVmax), cardiac metabolic volume (CMV), and cardiac metabolic activity (CMA) was calculated from FDG. CMR and FDG were fused and divided into AHA 17 model for segmental analysis. Wall motion, the magnitude of LGE in myocardial wall (LGE%wall), and corresponding FDG uptake (segmental SUVmax) were analyzed. Forty-one patients were retrospectively enrolled. In patients with FDG uptake, LVEF inversely correlated to LGE volume and positively correlated to SUVmax (r = − 0.56, p < 0.0001, and r = 0.08, p = 0.048, respectively). Discrepancy between LGE volume and CMV showed a significant positive correlation to whole SUVmax and CMA (r = 0.49, p < 0.0001, and r = 0.96, p < 0.0001, respectively). In image fusion analysis, segmental SUVmax showed a significant inverse correlation to LGE%wall (Spearman’s rank correlation coefficient; r = − 0.15, p = 0.008). LGE%wall also showed significant inverse correlation to wall motion (r = − 0.13, p = 0.0011). Combined and fusion analysis with CMR and FDG demonstrated the discrepancy of myocardial inflammation and extensive fibrosis. Active inflammation was present in the earlier stage of myocardial fibrosis and was found to be less in the wall with advanced fibrosis and remodeling. Combined analysis of CMR and FDG can incrementally reclassify the pathological stage of CS.
- Open Access
- 1 September 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 267, 202-207
Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease: J-ACCESS 4 study
- 1 September 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 267, 202-207
Open AccessPrognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease: J-ACCESS 4 study
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S71
Detection of Undiagnosed Cardiac Sarcoidosis by FDG-PET and SPECT among Patients With Atrioventricular Block Followed in a Pacemaker Outpatient Clinic
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S71
Detection of Undiagnosed Cardiac Sarcoidosis by FDG-PET and SPECT among Patients With Atrioventricular Block Followed in a Pacemaker Outpatient Clinic
- Open Access
- 22 September 2017
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 31 (9) , 649-659
IQ·SPECT technology and its clinical applications using multicenter normal databases
IQ·SPECT (Siemens Medical Solutions) is a solution for high-sensitivity and short-time acquisition imaging of the heart for a variable angle general purpose gamma camera. It consists of a multi-focal collimator, a cardio-centric orbit and advanced iterative reconstruction, modeling the image formation physics accurately. The multi-focal collimator enables distance-dependent enlargement of the center region while avoiding truncation at the edges. With the specified configuration and a cardio-centric orbit it can obtain a fourfold sensitivity increase for the heart at the center of the scan orbit. Since IQ·SPECT shows characteristic distribution patterns in the myocardium, appropriate acquisition and processing conditions are required, and normal databases are convenient for quantification of both normal and abnormal perfusion images. The use of prone imaging can be a good option when X-ray computed tomography (CT) is not available for attenuation correction. CT-based attenuation correction changes count distribution significantly in the inferior wall and around the apex, hence image interpretation training and additional use of normal databases are recommended. Recent reports regarding its technology, Japanese Society of Nuclear Medicine working group activities, and clinical studies using 201Tl and 99mTc-perfusion tracers in Japan are summarized.
- 22 September 2017
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 31 (9) , 649-659
Open AccessIQ·SPECT technology and its clinical applications using multicenter normal databases
IQ·SPECT (Siemens Medical Solutions) is a solution for high-sensitivity and short-time acquisition imaging of the heart for a variable angle general purpose gamma camera. It consists of a multi-focal collimator, a cardio-centric orbit and advanced iterative reconstruction, modeling the image formation physics accurately. The multi-focal collimator enables distance-dependent enlargement of the center region while avoiding truncation at the edges. With the specified configuration and a cardio-centric orbit it can obtain a fourfold sensitivity increase for the heart at the center of the scan orbit. Since IQ·SPECT shows characteristic distribution patterns in the myocardium, appropriate acquisition and processing conditions are required, and normal databases are convenient for quantification of both normal and abnormal perfusion images. The use of prone imaging can be a good option when X-ray computed tomography (CT) is not available for attenuation correction. CT-based attenuation correction changes count distribution significantly in the inferior wall and around the apex, hence image interpretation training and additional use of normal databases are recommended. Recent reports regarding its technology, Japanese Society of Nuclear Medicine working group activities, and clinical studies using 201Tl and 99mTc-perfusion tracers in Japan are summarized.
- 1 November 2016
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 31 (2) , 135-143
Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging
Cardiac sarcoidosis (CS) can be diagnosed using 18F-FDG-PET/CT (PET), cardiovascular magnetic resonance (CMR), and 123I-BMIPP/201TlCl dual myocardial SPECT. This study aims to clarify the relationships among the three modalities with respect to CS.
- 1 November 2016
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 31 (2) , 135-143
Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging
Cardiac sarcoidosis (CS) can be diagnosed using 18F-FDG-PET/CT (PET), cardiovascular magnetic resonance (CMR), and 123I-BMIPP/201TlCl dual myocardial SPECT. This study aims to clarify the relationships among the three modalities with respect to CS.
- 1 January 2016
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 80 (5) , 1265-1266
Steroid Therapy Ameliorated Myocardial Fatty Acid Metabolism With Recovery of Complete Atrioventricular Block in Cardiac Sarcoidosis
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2016
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 80 (5) , 1265-1266
Steroid Therapy Ameliorated Myocardial Fatty Acid Metabolism With Recovery of Complete Atrioventricular Block in Cardiac Sarcoidosis
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 October 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (10) , S163
The Combination Therapy of Corticosteroid and Mycophenolate Mofetil in a Case of Refractory Cardiac Sarcoidosis
- 1 October 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (10) , S163
The Combination Therapy of Corticosteroid and Mycophenolate Mofetil in a Case of Refractory Cardiac Sarcoidosis